Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity.

Indian J Med Res · 2013 · PMC3657903 · PMID 23481055

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to attain significanceno p-value reported

However, when the difference in prevalence of TTG antibodies was assessed separately in the two age categories, it failed to attain significance; whereas that for GAD antibodies persisted unchanged ( Table I ).

also in 59 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.